Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT.

NCT03990051 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Ocular Graft-versus-host Disease

Interventions

DRUG: Pro-ocular™ topical gel
DRUG: Placebo topical gel

Sponsor

Glia, LLC

Collaborators

[object Object]